A new medical research centre has opened at a North East hospital to increase the number of clinical trials carried out in the region.
The partnership will focus on clinical trials and is the first of its kind between a private company and the NHS. It is hoped that the collaboration will benefit patients in the area.
Prof Richard Walker, clinical director of research and development at Northumbria Healthcare NHS Foundation Trust, said: “At Northumbria we believe everyone should be able to take part in appropriate clinical trials if they would like to. This partnership will bring a wider variety of trials to the North East giving more people the chance to take part.
“We’re delighted to be working in partnership with Synexus. They are a very successful company with more than 20 years’ experience in running research centres worldwide.
“This partnership will provide us with opportunities to work together to deliver clinical research studies relating to a variety of conditions and usually will focus on those conditions which affect large numbers of people.”
Synexus runs clinical trials throughout the world working across a range of medical conditions. The idea behind the firm’s new approach is to increase the number of potentially complex studies being undertaken, with the support and experience of the clinical staff and services provided by the trust at the hospital.
Sarah Beeby, Synexus’ UK managing director, said: “This is a very exciting partnership as it potentially signals a new way of working for the clinical trials sector that will enable UK patients to access new treatments and will also help ensure the UK clinical trials industry remains competitive on the global stage.
“This is groundbreaking and, we hope, the start of something that will replicate across the UK so that even more people can benefit.”
Clinical trials are carried out in order to advance medical understanding and develop more effective treatments. Synexus and Northumbria Healthcare will focus on comparing new treatments with the best currently available treatment or a replacement.
Synexus conducts trials across a range of conditions with particular emphasis on cardiovascular, diabetes and obesity, musculo skeletal, respiratory and central nervous system trials. These clinical areas echo those in which Northumbria Healthcare carries out a number of research studies.